Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-gbm5v Total loading time: 0 Render date: 2025-01-03T02:00:58.790Z Has data issue: false hasContentIssue false

1 - Epidemiological and clinical aspects of human typhoid fever

Published online by Cambridge University Press:  04 December 2009

Duncan Maskell
By
Christopher M. Parry
Edited by
Pietro Mastroeni
Duncan Maskell
Affiliation:
University of Cambridge
Christopher M. Parry
Affiliation:
Department of Medical Microbiology and Genitourinary Medicine, Duncan Building, University of Liverpool, Daulby Street, Liverpool L69 3GA, UK
Pietro Mastroeni
Affiliation:
University of Cambridge
Get access

Summary

INTRODUCTION

Typhoid fever is an acute systemic infection caused by the bacterium Salmonella enterica serovar Typhi. Salmonella enterica serovars Paratyphi A, B, and C cause the clinically similar condition, paratyphoid fever. Typhoid and paratyphoid fevers are collectively referred to as enteric fevers. In most endemic areas, approximately 90% of enteric fever is typhoid. Typhoid is transmitted by the fecal-oral route via contaminated food and water and is therefore common where sanitary conditions are inadequate and access to clean water is limited. Although typhoid fever was common in the United States and Europe in the 19th century, it is now encountered mostly throughout the developing world. In the last fifteen years, the emergence of resistance to the antibiotics used for treatment has led to large epidemics, and complicated the management of this serious disease.

Before the 19th century, typhoid fever was commonly confused with other prolonged febrile syndromes, particularly typhus fever. Following the observations of Huxham, Louis, Bretonneau, Gerhard and William Jenner, by the middle of the 19th century the two conditions were clearly differentiated (Richens, 1996). In 1873, William Budd described the contagious nature of the disease and incriminated fecally contaminated water sources in transmission. The causative organism was visualized in tissue sections from Peyer's patches and spleens of infected patients by Eberth in 1880 and was grown in pure culture by Gaffky in 1884. The organism has been variously known as Bacillus typhosus, Erbethella typhosa, Salmonella typhosa and Salmonella typhi.

Type
Chapter
Information
Salmonella Infections
Clinical, Immunological and Molecular Aspects
 , pp. 1 - 24
Publisher: Cambridge University Press
Print publication year: 2006

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Acharya, I. L., Lowe, C. U., Thapa, R.et al. (1987). Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med, 317, 1101–4.CrossRefGoogle ScholarPubMed
Ackers, M. L., Puhr, N. D., Tauxe, R. V. and Mintz, E. D. (2000). Laboratory-based surveillance of Salmonella serotype Typhi infections in the United States: antimicrobial resistance on the rise. JAMA, 283, 2668–73.CrossRefGoogle ScholarPubMed
Ashcroft, M. T. (1964). Typhoid and Paratyphoid fever in the tropics. J Trop Med Hyg, 67, 185–9.Google ScholarPubMed
Bethell, D. B., Hien, T. T., Phi, L. T.et al. (1996). Effects on growth of single short courses of fluoroquinolones. Arch Dis Child, 74, 44–6.CrossRefGoogle ScholarPubMed
Bhan, M. K., Bahl, R., Sazawal, S.et al. (2002). Association between Helicobacter pylori infection and increased risk of typhoid fever. J Infect Dis, 186, 1857–60.CrossRefGoogle ScholarPubMed
Bhutta, Z. A. (1996a). Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child, 75, 214–17.CrossRefGoogle Scholar
Bhutta, Z. A (1996b). Therapeutic aspects of typhoidal salmonellosis in childhood: the Karachi experience. Ann Trop Paed, 16, 299–306.CrossRefGoogle Scholar
Bhutta, Z. A. and Mansurali, N. (1999). Rapid serological diagnosis of pediatric typhoid fever in an endemic area: a prospective comparative evaluation of two dot-enzyme immunoassays and the Widal test. Am J Trop Med Hyg, 61, 654–7.CrossRefGoogle Scholar
Black, R. E., Cisneros, L., Levine, M. M.et al. (1985). Case-control study to identify risk factors for paediatric endemic typhoid fever in Santiago, Chile. Bull WHO, 43, 899–904.Google Scholar
Bodhidatta, L., Taylor, D. N., Thisyakorn, U. and Echeverria, P. (1987). Control of typhoid fever in Bangkok, Thailand, by annual immunisation of schoolchildren with parenteral typhoid vaccine. Rev Infect Dis, 9, 841–5.CrossRefGoogle ScholarPubMed
Brenner, F. W., Villar, R. G., Angulo, F. J., Tauxe, R. and Swaminathan, B. (2000). Salmonella nomenclature. J Clin Microbiol, 38, 2465–7.Google ScholarPubMed
Brown, J. C., Shanahan, P. M., Jesudason, M. V., Thomson, C. J. and Aymes, S. G. (1996). Mutations responsible for reduced susceptibility to 4-quinolones in clinical isolates of multi-resistant Salmonella typhi in India. J Antimicrob Chemother, 37, 891–900.CrossRefGoogle ScholarPubMed
Butler, T., Bell, W. R., Levin, J., Linh, N. N. and Arnold, K. (1978). Typhoid Fever. Studies of blood coagulation, bacteremia and endotoxaemia. Arch Intern Med, 138, 407–10.CrossRefGoogle Scholar
Butler, T., Islam, A., Kabir, I. and Jones, P. K. (1991). Patterns of morbidity and mortality in typhoid fever dependent on age and gender: a review of 552 hospitalised patients with diarrhoea. Rev Infect Dis, 13, 85–90.CrossRefGoogle Scholar
Butler, T., Knight, J., Nath, S. K.et al. (1985). Typhoid fever complicated by intestinal perforation: a persisting fatal disease requiring surgical management. Rev Infect Dis, 7, 244–56.CrossRefGoogle ScholarPubMed
Caygill, C. P. J., Hill, M. J., Braddick, M. and Sharp, J. C. M. (1994). Cancer mortality in chronic typhoid and paratyphoid carriers. Lancet, 343, 83–4.CrossRefGoogle ScholarPubMed
Chaudhry, R., Laxmi, B. V., Nisar, N., Ray, K. and Kumar, D. (1997). Standardisation of polymerase chain reaction for the detection of Salmonella typhi in typhoid fever. J Clin Pathol, 50, 437–9.CrossRefGoogle ScholarPubMed
Chinh, N. T., Parry, C. M., Ly, N. T.et al. (2000). A randomised controlled comparison of azithromycin and ofloxacin for multidrug-resistant and nalidixic acid resistant enteric fever. Antimicrob Agents Chemother, 44, 1855–9.CrossRefGoogle Scholar
Clegg, A., Passey, M., Omena, M., Karigifa, K. K. and Suve, N. (1994). Re-evaluation of the Widal agglutination test in response to the changing pattern of typhoid fever in the highlands of Papua New Guinea. Acta Tropica, 57, 255–63.CrossRefGoogle ScholarPubMed
Crump, J. A., Barrett, T. J., Nelson, J. T. and Angulo, F. J. (2003a). Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salmonellae. Clin Infect Dis, 37, 75–81.CrossRefGoogle Scholar
Crump, J. A., Youssef, F. G., Luby, S. P.et al. (2003b). Estimating the incidence of Typhoid Fever and other febrile illnesses in developing countries. Emerg Infect Dis, 9, 539–44.CrossRefGoogle Scholar
Crump, J. A., Luby, S. P. and Mintz, E. D. (2004). The global burden of typhoid fever. Bull World Health Org, 82, 346–53.Google ScholarPubMed
Doherty, C. P., Saha, S. K. and Cutting, W. M. (2000). Typhoid fever, ciprofloxacin and growth in young children. Ann Trop Paed, 20, 297–303.CrossRefGoogle ScholarPubMed
Duggan, M. B. and Beyer, L. (1975). Enteric fever in young Yoruba children. Arch Dis Child, 50, 67–71.CrossRefGoogle ScholarPubMed
Dutta, P., Mitra, U., Dutta, S., De, A., Chatterjee, M. K. and Bhattacharya, S. K. (2001). Ceftriaxone therapy in ciprofloxacin treatment failure in children. Indian J Med Res, 113, 210–13.Google ScholarPubMed
Dutta, P., Rasaily, R., Saha, M. R.et al. (1993). Ciprofloxacin for treatment of severe typhoid fever in children. Antimicrob Agents Chemother, 37, 1197–9.CrossRefGoogle ScholarPubMed
Engels, E. A., Falagas, M. E., Lau, J. and Bennish, M. L. (1998). Typhoid fever vaccines: a meta-analysis of studies on efficacy and toxicity. Br Med J, 316, 110–16.CrossRefGoogle ScholarPubMed
Everest, P., Wain, J., Roberts, M., Rook, G. and Dougan, G. (2001). The molecular mechanisms of severe typhoid fever. Trends Microbiol, 9, 316–20.CrossRefGoogle ScholarPubMed
Ferreccio, C., Levine, M. M., Manterola, A.et al. (1984). Benign bacteraemia caused by Salmonella typhi and paratyphi in children younger than two years. J Pediatr, 104, 899–901.CrossRefGoogle Scholar
Ferreccio, C., Morris, J. G., Valdiviseo, C.et al. (1988). Efficacy of ciprofloxacin in the treatment of chronic typhoid carriers. J Infect Dis, 157, 1235–9.CrossRefGoogle ScholarPubMed
Garmory, H. S., Brown, K. A. and Titball, R. W. (2002). Salmonella vaccines for use in humans: present and future perspectives. FEMS Microbiol Rev, 26, 339–53.Google ScholarPubMed
Gasem, M. H., Dolmans, W. M. V., Keuter, M. and Djokomoeljanto, R. (2001). Poor food hygiene and housing as risk factors for typhoid fever in Semarang, Indonesia. Trop Med Int Hlth, 6, 484–90.CrossRefGoogle ScholarPubMed
Gilman, R. H., Terminel, M., Levine, M. M., Hernandez-Mendoze, P. and Hornick, R. B. (1975). Relative efficacy of blood, urine, rectal swab, bone marrow and rose spot cultures for recovery of Salmonella typhi in typhoid fever. Lancet, 1, 1211–13.CrossRefGoogle ScholarPubMed
Gotuzzo, E., Guerra, J. G., Benavente, L.et al. (1988). Use of norfloxacin to treat chronic typhoid carriers. J Infect Dis, 157, 1221–5.CrossRefGoogle ScholarPubMed
Hatta, M., Mubin, H., Abdoel, T. and Smits, H. L. (2002). Antibody response in typhoid fever in endemic Indonesia and the relevance of serology and culture to diagnosis. Southeast Asian J Trop Med Hyg, 33, 742–51.Google Scholar
Hien, T. T., Bethell, D. B., Hoa, N. T. T.et al. (1995). Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis, 20, 917–23.CrossRefGoogle Scholar
Hoffman, S. L., Edman, D. C., Punjabi, N. H.et al. (1986). Bone marrow aspirate culture superior to streptokinase clot culture and 8 ml 1:10 blood-to-broth ratio blood culture for diagnosis of typhoid fever. Am J Trop Med Hyg, 35, 836–9.CrossRefGoogle ScholarPubMed
Hoffman, S. L., Punjabi, N. H., Kumala, S.et al. (1984a). Reduction of mortality in chloramphenicol-treated severe typhoid fever by high dose dexamethasone. N Engl J Med, 310, 82–8.CrossRefGoogle Scholar
Hoffman, S. L., Punjabi, N. H., Rockhill, R. C.et al. (1984b). Duodenal string-capsule culture compared with bone-marrow, blood, and rectal-swab cultures for diagnosing typhoid and paratyphoid fever. J Infect Dis, 149, 157–61.CrossRefGoogle Scholar
Hornick, R. B., Greisman, S. E., Woodward, T. E.et al. (1970). Typhoid fever: pathogenesis and immunological control. N Engl J Med, 283, 686–91 and 739–46.CrossRefGoogle Scholar
House, D., Bishop, A., Parry, C. M., Dougan, G. and Wain, J. (2001a). Typhoid fever: pathogenesis and disease. Curr Opinions in Infect Dis, 14, 573–8.CrossRefGoogle Scholar
House, D., Wain, J., Ho, V. A.et al. (2001b). The serology of typhoid fever in an endemic area and its relevance to diagnosis. J Clin Microbiol, 39, 1002–7CrossRefGoogle Scholar
Huckstep, R. L. (1962). Typhoid fever and other “Salmonella” infections. Edinburgh and London: Livingstone.Google Scholar
Kariuki, S., Gilks, C., Revathi, G., Hart, C. A. (2000). Genotypic analysis of multidrug-resistant Salmonella enterica serovar Typhi, Kenya. Emerg Infect Dis, 6, 649–51.CrossRefGoogle ScholarPubMed
Klugman, K. P., Gilbertson, I. T., Koornhof, H. J.et al. (1987). Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet, 2, 1165–9.CrossRefGoogle ScholarPubMed
Klugman, K. P., Koornhof, H. J., Robbins, J. B. and Cam, N. N. L. (1996). Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine, 14, 435–8.CrossRefGoogle ScholarPubMed
Koul, P. A., Wani, J. I. and Wahid, A. (1995). Ciprofloxacin for multiresistant enteric fever in pregnancy. Lancet, 346, 307–8.CrossRefGoogle ScholarPubMed
Lanata, C. F., Levine, M. M., Ristori, C., Black, R. E., Jiminez, L., Salcedo, M., Garcia, J. and Sotomayor, V. (1983) Vi serology in detection of chronic Salmonella typhi carriers in an endemic area. Lancet, 2, 441–3.CrossRefGoogle Scholar
Lanh, M. N., Bay, P. V., Ho, V. A.et al. (2003). Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children. N Engl J Med, 349, 1390–1.CrossRefGoogle Scholar
Levine, M. M., Ferreccio, C., Black, R. E. and Germanier, R. (1987). Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation. Lancet, 1, 1049–52.CrossRefGoogle ScholarPubMed
Levine, M. M., Ferrecio, C., Cryz, S. and Ortiz, E. (1990). Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomized controlled field trial. Lancet, 336, 891–4.Google Scholar
Levine, M. M., Grados, O., Gilman, R. H.et al. (1978). Diagnostic value of the Widal test in areas endemic for typhoid fever. Am J Trop Med Hyg, 27, 795–800.CrossRefGoogle ScholarPubMed
Lin, F. Y. C., Ho, V. A., Bay, P. V.et al. (2000). The epidemiology of typhoid fever in the Dong Thap province, Mekong Delta region of Vietnam. Am J Trop Med Hyg, 62, 644–8.CrossRefGoogle ScholarPubMed
Lin, F. Y. C., Ho, V. A., Khiem, H. B.et al. (2001). The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med, 344, 1263–9.CrossRefGoogle ScholarPubMed
Luby, S. P., Faizan, M. K., Fisher-Hoch, S. P.et al. (1998). Risk factors for typhoid fever in an endemic setting, Karachi, Pakistan. Epidemiol Infect, 120, 129–38.CrossRefGoogle Scholar
Luxemburger, C., Duc, C. N., Lanh, M. N.et al. (2001). Risk factors for Typhoid fever in the Mekong Delta, southern Vietnam: a case-control study. Trans R Soc Trop Med Hyg, 95, 19–23.CrossRefGoogle ScholarPubMed
Mahle, W. T. and Levine, M. M. (1993). Salmonella typhiinfection in children younger than five years of age. Pediatr Infect Dis J, 12, 627–31.CrossRefGoogle ScholarPubMed
Marmion, D. E., Naylor, G. R. E. and Stewart, I. O. (1953). Second attacks of typhoid fever. J Hyg (Camb), 51, 260–7.CrossRefGoogle ScholarPubMed
Mehta, G., Randhawa, V. S. and Mohapatra, N. P. (2001). Intermediate susceptibility to ciprofloxacin in Salmonella typhistrains in India. Eur J Clin Microbiol Infect Dis, 20, 760–1.CrossRefGoogle ScholarPubMed
Mermin, J. H., Villar, R., Carpenter, J.et al. (1999). A massive epidemic of multidrug-resistant typhoid fever in Tajikistan associated with consumption of municipal water. J Infect Dis, 179, 1416–22.CrossRefGoogle ScholarPubMed
Morris, J. G., Ferreccio, C., Garcia, J.et al. (1984). Typhoid fever in Santiago, Chile: a study of household contacts of pediatric patients. Am J Trop Med Hyg, 33, 1198–202.CrossRefGoogle Scholar
Parry, C. M. (2004). The treatment of multidrug resistant and nalidixic acid resistant typhoid fever in Vietnam. Trans Roy Soc Trop Med Hyg, 98, 413–22.CrossRefGoogle Scholar
Parry, C. M, Hien, T. T., Dougan, G., White, N. J. and Farrar, J. J. (2002). Typhoid Fever. N Engl J Med, 347, 1770–82.CrossRefGoogle ScholarPubMed
Parry, C. M., Hoa, N. T., Diep, T. S.et al. (1999). Value of a single-tube Widal test in diagnosis of typhoid fever in Vietnam. J Clin Microbiol, 37, 2882–6.Google ScholarPubMed
Punjabi, N. H., Hoffman, S. L., Edman, D. C.et al. (1988). Treatment of severe typhoid fever in children with high dose dexamethasone. Pediatr Infect Dis J, 7, 598–600.CrossRefGoogle ScholarPubMed
Reed, R. P. and Klugman, K. P. (1994). Neonatal typhoid fever. Pediatr Infect Dis J, 13, 774–7.CrossRefGoogle ScholarPubMed
Richens, J. (1996). Typhoid. In The Wellcome Trust Illustrated History of Tropical Diseases, ed. Cox, F. E. G.. London: Wellcome Trust.Google Scholar
Rodrigues, C., Shenai, S. and Mehta, A. (2003). Enteric fever in Mumbai, India: the good news and the bad news. Clin Infect Dis, 36, 535.CrossRefGoogle ScholarPubMed
Rogerson, S. J., Spooner, V. J., Smith, T. A. and Richens, J. (1991). Hydrocortisone in chloramphenicol-treated severe typhoid fever in Papua New Guinea. Trans Roy Soc Trop Med Hyg, 85, 113–16.CrossRefGoogle ScholarPubMed
Rowe, B., Ward, L. R. and Threlfall, E. J. (1997). Multidrug-resistant Salmonella typhi: a worldwide epidemic. Clin Infect Dis, 24(suppl. 1), S106–9.CrossRefGoogle Scholar
Rupali, P., Abraham, O. C., Jesudason, M. V.et al. (2004). Treatment failure in typhoid fever with ciprofloxacin susceptible Salmonella enterica serotype Typhi. Diagn Microbiol Infect Dis, 49, 1–3.CrossRefGoogle ScholarPubMed
Saha, S. K., Talukder, S. Y., Islam, M. and Saha, S. (1999). A highly ceftriaxone-resistant Salmonella typhi in Bangladesh. Pediatr Infect Dis J, 18, 387.CrossRefGoogle ScholarPubMed
Seoud, M., Saade, G., Uwaydah, M. and Azoury, R. (1988). Typhoid fever in pregnancy. Obstet Gynecol, 71, 711–14.Google ScholarPubMed
Simanjuntak, C. H., Paleologo, F. P., Punjabi, N. H.et al. (1991). Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine. Lancet, 338, 1055–9.CrossRefGoogle ScholarPubMed
Sinha, A., Sazawal, S., Kumar, R.et al. (1999). Typhoid fever in children aged less than five years. Lancet, 354, 734–7.CrossRefGoogle Scholar
Stephens, I. and Levine, M. M. (2002). Management of typhoid fever in children. Pediatr Infect Dis J, 21, 157–9.CrossRefGoogle ScholarPubMed
Stuart, B. M. and Pullen, R. L. (1946). Typhoid. Clinical analysis of three hundred and sixty cases. Arch Intern Med, 78, 629–61.CrossRefGoogle Scholar
Tarr, P. E., Kuppens, L., Jones, T. C.et al. (1999). Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan. Am J Trop Med Hyg, 61, 163–70.CrossRefGoogle Scholar
Taylor, D. N., Levine, M. M., Kuppens, L. and Ivanoff, B. (1999). Why are typhoid vaccines not recommended for epidemic typhoid fever?J Infect Dis, 180, 2089–90.CrossRefGoogle Scholar
Thong, K. L., Cheong, Y. M., Puthucheary, S., Koh, C. L. and Pang, T. (1994). Epidemiologic analysis of sporadic Salmonella typhi isolates and those from outbreaks by pulsed-field electrophoresis. J Clin Microbiol, 32, 1135–41.Google Scholar
Threlfall, E. J., Skinner, J. A., Ward, L. R. (2001). Detection of decreased in vitro susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A. J Antimicrob Chemother, 48, 740–1.CrossRefGoogle ScholarPubMed
Topley, J. M. (1986). Mild typhoid fever. Arch Dis Child, 61, 164–7.CrossRefGoogle ScholarPubMed
Velema, J. P., Wijnen, G., Bult, P., Naerssen, T. and Jota, S. (1997). Typhoid fever in Ujung Pandang, Indonesia – high-risk groups and high-risk behaviours. Trop Med Int Health, 2, 1088–94.CrossRefGoogle ScholarPubMed
Wahdan, M. H., Sérié, C., Cerisier, Y., Sallam, S. and Germanier, R. (1982). A controlled field trial of live Salmonella typhi strain Ty21a oral vaccine against typhoid: three-year results. J Infect Dis, 145, 292–5.CrossRefGoogle Scholar
Wain, J., Bay, P. V. B., Vinh, H.et al. (2001). Quantitation of bacteria in bone marrow from patients with Typhoid Fever: relationship between counts and clinical features. J Clin Microbiol, 39, 1571–6.CrossRefGoogle ScholarPubMed
Wain, J., Diep, T. S., Ho, V. A.et al. (1998). Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance. J Clin Microbiol, 36, 1683–7.Google ScholarPubMed
Wain, J., Hoa, N. T., Chinh, N. T. T.et al. (1997). Quinolone-resistant Salmonella typhi in Viet Nam: molecular basis of resistance and clinical response to treatment. Clin Infect Dis, 25, 1404–10.CrossRefGoogle ScholarPubMed
Wasfy, M. O., Frenck, R., Ismail, T. F.et al. (2002). Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis, 35, 1265–8.CrossRefGoogle ScholarPubMed
Woodward, T. E., Smadel, J. E., Ley, H. L., Green, R. and Mankikar, D. S. (1948). Preliminary report on the beneficial effect of chloromycetin in the treatment of typhoid fever. Ann Intern Med, 29, 131–4.Google ScholarPubMed
World Health Organization background document. The diagnosis, treatment and prevention of typhoid fever. WHO/V&B/03.07 (2003). Accessed at www.who.int/vaccines-documents/DocsPDF03/www740.pdf on 15.03.04.
Yang, H. H., Wu, C. G., Xie, G. Z.et al. (2001). Efficacy trial of Vi polysaccharide vaccine against typhoid fever in South-Western China. Bull WHO, 79, 625–31.Google ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×